Users online: 928    [ij] [ij] [ij] 
Email id

Research Journal of Pharmaceutical Dosage Forms and Technology
Year : 2020, Volume : 12, Issue : 3
First page : ( 178) Last page : ( 180)
Print ISSN : 0975-234X. Online ISSN : 0975-4377.
Article DOI : 10.5958/0975-4377.2020.00030.0

A Review on Severe Acute Respiratory Infection (SARI) and its Clinical Management in Suspect/Confirmed Novel Coronavirus (nCoV) Cases

Yadav Akshay R.*, Mohite Shrinivas K.

Department of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy, Kasegaon, Dist-Sangli, Maharashtra, India-415404

*Corresponding Author E-mail: akshayyadav24197@gmail.com

Online published on 10 August, 2020.


SARI is the most of viral infections that cause generalised clinical symptoms that cannot be easily differentiated from other respiratory infections. Monitoring SARI cases of influenza strains such as H1N1 and Sars-Cov-2, which triggers Covid-19, helps create trends of infection nationally and enhances disease monitoring, which informs response and preparedness to containment. In present article information about genome, Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel coronavirus (nCoV) cases by immediate implementation of appropriate IPC measures, early supportive therapy and monitoring, management of hypoxemic respiratory failure, management of septic shock and specific anti-Novel-CoV treatments were given.



SARI, Covid-19, genome, clinical management, supportive therapy.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
598,034,567 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.